Please login to the form below

Not currently logged in
Email:
Password:

InterComm International under new management

Malcolm Allison and Ben Greeves take over the med comms agency

InterComm InternationalMedical communications agency InterComm International has changed ownership, with Malcolm Allison and Ben Greeves acquiring the firm.

Based in Cambridge, UK, InterComm had been under the leadership of chief executive Martin Lancaster and managing director David Mercer since 1998.

Allison and Greeves took over the reins in September as director and general manager respectively, working to deliver multichannel campaigns in the pharmaceutical and healthcare arena.

Outlining the agency's focus, Greeves told PMLiVE: “We want to be known for delivering excellence with integrity.

“We have a great team with experience across many different clients, covering assets including medical devices, pharmaceuticals, animal health and consumer brands.”

Greeves first joined InterComm six years ago after establishing his own digital solutions firm, while Allison brings over 30 years of pharmaceutical marketing experience to the agency.

With strategic and tactical marketing and sales experience accrued while at Actelion, Bayer, GlaxoSmithKline, Novartis and Pfizer, Allison described his agency-side move as “a natural progression”.

He told PMLiVE: “We want to help clients tell their story. As InterComm moves forward under new management, we will continue working in this fast-paced industry, delivering materials that excite, educate and inform.”

Article by
Rebecca Clifford

8th December 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics